BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 32913188)

  • 1. A small molecular compound CC1007 induces cross-lineage differentiation by inhibiting HDAC7 expression and HDAC7/MEF2C interaction in BCR-ABL1
    Wang Z; Zhang Y; Zhu S; Peng H; Chen Y; Cheng Z; Liu S; Luo Y; Li R; Deng M; Xu Y; Hu G; Chen L; Zhang G
    Cell Death Dis; 2020 Sep; 11(9):738. PubMed ID: 32913188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CC1007, a small molecular compound, suppresses multiple myeloma via upregulation of Nur77.
    Zhu S; Xing C; Zhang G; Peng H; Wang Z
    Bioorg Chem; 2022 Dec; 129():106217. PubMed ID: 36283176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCR-ABL1 induces aberrant splicing of IKAROS and lineage infidelity in pre-B lymphoblastic leukemia cells.
    Klein F; Feldhahn N; Herzog S; Sprangers M; Mooster JL; Jumaa H; Müschen M
    Oncogene; 2006 Feb; 25(7):1118-24. PubMed ID: 16205638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The transcriptional repressor HDAC7 promotes apoptosis and c-Myc downregulation in particular types of leukemia and lymphoma.
    Barneda-Zahonero B; Collazo O; Azagra A; Fernández-Duran I; Serra-Musach J; Islam AB; Vega-García N; Malatesta R; Camós M; Gómez A; Román-González L; Vidal A; López-Bigas N; Villanueva A; Esteller M; Parra M
    Cell Death Dis; 2015 Feb; 6(2):e1635. PubMed ID: 25675295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HDAC7 is a repressor of myeloid genes whose downregulation is required for transdifferentiation of pre-B cells into macrophages.
    Barneda-Zahonero B; Román-González L; Collazo O; Rafati H; Islam AB; Bussmann LH; di Tullio A; De Andres L; Graf T; López-Bigas N; Mahmoudi T; Parra M
    PLoS Genet; 2013 May; 9(5):e1003503. PubMed ID: 23696748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo conditional deletion of HDAC7 reveals its requirement to establish proper B lymphocyte identity and development.
    Azagra A; Román-González L; Collazo O; Rodríguez-Ubreva J; de Yébenes VG; Barneda-Zahonero B; Rodríguez J; Castro de Moura M; Grego-Bessa J; Fernández-Duran I; Islam AB; Esteller M; Ramiro AR; Ballestar E; Parra M
    J Exp Med; 2016 Nov; 213(12):2591-2601. PubMed ID: 27810920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The BCR-ABL1 kinase bypasses selection for the expression of a pre-B cell receptor in pre-B acute lymphoblastic leukemia cells.
    Klein F; Feldhahn N; Harder L; Wang H; Wartenberg M; Hofmann WK; Wernet P; Siebert R; Müschen M
    J Exp Med; 2004 Mar; 199(5):673-85. PubMed ID: 14993251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reprogramming of primary human Philadelphia chromosome-positive B cell acute lymphoblastic leukemia cells into nonleukemic macrophages.
    McClellan JS; Dove C; Gentles AJ; Ryan CE; Majeti R
    Proc Natl Acad Sci U S A; 2015 Mar; 112(13):4074-9. PubMed ID: 25775523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase 7 (HDAC7) regulates myocyte migration and differentiation.
    Gao C; Liu Y; Lam M; Kao HY
    Biochim Biophys Acta; 2010 Oct; 1803(10):1186-97. PubMed ID: 20621129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Converse role of class I and class IIa HDACs in the progression of atrial fibrillation.
    Zhang D; Hu X; Li J; Hoogstra-Berends F; Zhuang Q; Esteban MA; de Groot N; Henning RH; Brundel BJJM
    J Mol Cell Cardiol; 2018 Dec; 125():39-49. PubMed ID: 30321539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dynamic role for HDAC7 in MEF2-mediated muscle differentiation.
    Dressel U; Bailey PJ; Wang SC; Downes M; Evans RM; Muscat GE
    J Biol Chem; 2001 May; 276(20):17007-13. PubMed ID: 11279209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High frequency of BTG1 deletions in patients with BCR-ABL1-positive acute leukemia.
    Xie J; Wang Q; Wang Q; Yao H; Wen L; Ma L; Wu D; Chen S
    Cancer Genet; 2014 May; 207(5):226-30. PubMed ID: 24998463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism for nucleocytoplasmic shuttling of histone deacetylase 7.
    Kao HY; Verdel A; Tsai CC; Simon C; Juguilon H; Khochbin S
    J Biol Chem; 2001 Dec; 276(50):47496-507. PubMed ID: 11585834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The black sheep of class IIa: HDAC7 SIKens the heart.
    Travers JG; Hu T; McKinsey TA
    J Clin Invest; 2020 Jun; 130(6):2811-2813. PubMed ID: 32364532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent induction of apoptosis by givinostat in BCR-ABL1-positive and BCR-ABL1-negative precursor B-cell acute lymphoblastic leukemia cell lines.
    Yao C; Zhang G; Walker A; Zhao KY; Li Y; Lyu L; Tang Y; Ru P; Jones D; Zhao W
    Leuk Res; 2017 Sep; 60():129-134. PubMed ID: 28818808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MEF2C and EBF1 Co-regulate B Cell-Specific Transcription.
    Kong NR; Davis M; Chai L; Winoto A; Tjian R
    PLoS Genet; 2016 Feb; 12(2):e1005845. PubMed ID: 26900922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the function of class IIa HDACs by blocking their interaction with MEF2.
    Jayathilaka N; Han A; Gaffney KJ; Dey R; Jarusiewicz JA; Noridomi K; Philips MA; Lei X; He J; Ye J; Gao T; Petasis NA; Chen L
    Nucleic Acids Res; 2012 Jul; 40(12):5378-88. PubMed ID: 22396528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone deacetylase inhibitors selectively suppress expression of HDAC7.
    Dokmanovic M; Perez G; Xu W; Ngo L; Clarke C; Parmigiani RB; Marks PA
    Mol Cancer Ther; 2007 Sep; 6(9):2525-34. PubMed ID: 17876049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1
    Schjerven H; Ayongaba EF; Aghajanirefah A; McLaughlin J; Cheng D; Geng H; Boyd JR; Eggesbø LM; Lindeman I; Heath JL; Park E; Witte ON; Smale ST; Frietze S; Müschen M
    J Exp Med; 2017 Mar; 214(3):793-814. PubMed ID: 28190001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. γ-Catenin-Dependent Signals Maintain BCR-ABL1
    Luong-Gardiol N; Siddiqui I; Pizzitola I; Jeevan-Raj B; Charmoy M; Huang Y; Irmisch A; Curtet S; Angelov GS; Danilo M; Juilland M; Bornhauser B; Thome M; Hantschel O; Chalandon Y; Cazzaniga G; Bourquin JP; Huelsken J; Held W
    Cancer Cell; 2019 Apr; 35(4):649-663.e10. PubMed ID: 30991025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.